Answers are grounded in this paper and cite their sources.
Case report shows dupilumab improved skin severity and heart function in a patient with AD and cardiovascular comorbidities, indicating its dual benefit.
Atopic dermatitis (AD) is a chronic inflammatory skin condition often complicated by cardiovascular comorbidities, impacting treatment options and outcomes. In this paper, we present a 41-year-old patient with severe AD, asthma, and chronic heart failure, who responded well to dupilumab, showing significant improvements in skin severity scores and heart function. This case underscores the effectiveness of dupilumab in managing AD alongside complex comorbidities.
No takes yet. Share an insight, caveat, or question.
Głuszak et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: